744
Genital Tract Diffusion of Different HIV PI in HIV-1-infected Pregnant Women
Gilles Peytavin*1, R Tubiana2, C Ferreira3, C Crenn-Hebert3, B Visseaux1, A G Marcelin2, M Dommergues2, and L Mandelbrot3
1Hosp Bichat-Claude Bernard, Paris, France; 2Hosp Pitie-Salpetriere, Paris, France; and 3Hosp L Mourier, Colombes, France
Background: Data on female genital
tract diffusion of protease inhibitors (PI) during pregnancy are scarce,
despite the potential role of the HIV presence in vaginal secretions in
vertical transmission. Our objective
was to evaluate the penetration of different PI in genital tract of
HIV-infected pregnant women.
Methods: Paired plasma and
cervico-vaginal concentrations of atazanavir (ATV), amprenavir
(APV), indinavir (IDV), lopinavir (LPV), nelfinavir
(NFV), and saquinavir (SQV) were determined using
high performance liquid chromatography (HPLC) coupled with photodiode
array-ultraviolet (PDA-UV) detection. Genital fluids were collected using
cervico-vaginal lavage and blotting paper from the posterior fornix and endocervical canal in HIV-1-infected pregnant women. Plasma
HIV RNA (pVL) and CD4 cell count were determined at
the time of pharmacokinetic sampling. Median (IQR 25 to 75) was presented.
Results: We enrolled in this pilot study,
20 HIV-1-infected pregnant women (aged 33 years, 30 to 35) (25 weeks of
gestation; 22 to 30), treated with a PI-containing regimen. In 18 of 20
patients, plasma viral loads were <200 copies/mL;
2 patients had detectable plasma viral loads, 1 for non-compliance and 1 in the
early phase of plasma viral loads decrease. CD4 count was 349/µL (264 to 552).
Plasma concentrations were 744 ng/mL (n = 8) for ATV, 808 ng/mL
(n = 2) for IDV, 4548 ng/mL (n = 5) for
LPV, 2964 ng/mL (n
= 2) for APV, 988 ng/mL (n = 1) for SQV, and 3870 ng/mL (n = 1) for NFV. Similar results were
obtained between cervico-vaginal lavage
and blotting paper from the posterior fornix and endocervical
canal regarding PI diffusion. LPV and SQV demonstrated no diffusion in vaginal
fluids (<300 and <200 ng/mL, respectively); the
cervicovaginal/plasma concentration ratios for ATV,
IDV, APV, and NFV were 84%, 371%, 30%, and 72%, respectively.
Conclusions: In this pilot study, cervico-vaginal lavage and
blotting paper allowed to collect cervicovaginal fluids with consistent
results. Major differences in cervico-vaginal diffusion between PI were found,
which may be related to characteristics of these drugs (protein binding,
lipo-solubility).
|